Skip to content
Aperlena

Czech Republic - Antineoplastics - Medicinal products containing erdafitinib, daunorubicin with cytarabine and mirikizumab

Original Česko - Antineoplastika - Léčivé přípravky s obsahem erdafitinibu, daunorubicinu s cytarabinem a mirikizumabu

Open Contract notice 10 days left
Watch this tender

Deadline 6 Oct. If it moves, an email when the register sees it. A correction: the same email. Log in

  1. Published
  2. Today
  3. Deadline open for 29 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 82 different companies have won the last 135 comparable contracts from this buyer over 5 years. This is a genuinely open race.

-24.7%
Expected final price vs the published estimate

Based on 135 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The contracting authority in the Czech Republic is procuring recurrent supplies of medicinal products containing erdafitinib, daunorubicin with cytarabine and mirikizumab, used as antineoplastic (cancer) treatments. The tender is divided into three parts: supplies of erdafitinib for 4 years, supplies of daunorubicin with cytarabine for 4 years, and supplies of mirikizumab until 18.9.2029, in each case according to the buyer's current needs. Suppliers of the specified medicinal products may bid.

Description

Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem erdafitinibu, daunorubicinu s cytarabinem a mirikizumabu pro část 1 a 2 po dobu 4 let a pro část 3 do 18.9.2029 dle aktuálních potřeb zadavatele. Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem erdafitinibu po dobu 4 let dle aktuálních potřeb zadavatele.; Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem a mirikizumabu do 18.9.2029 dle aktuálních potřeb zadavatele.; Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem daunorubicinu s cytarabinem po dobu 4 let dle aktuálních potřeb zadavatele.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago

More from this buyer

Full buyer profile

23 open tenders right now

Who usually wins this buyer's contracts in this sector

Based on 135 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 135 comparable contracts this buyer awarded in this sector over the last 4 years.

€109,009
Lower quartile
€278,114
Median award
€946,039
Upper quartile

This tender is estimated 621.4% above that median

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,070,574
9,859 open across Europe right now 80% below sector average
Buyer track record on Aperlena
551 notices tracked · 294 awarded
€251,827,934 in awarded contracts

Never miss a tender like this

177 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close